Current treatment paradigms and emerging therapies for NAFLD/NASH S Raza, S Rajak, A Upadhyay, A Tewari, RA Sinha Frontiers in bioscience (Landmark edition) 26, 206, 2021 | 253 | 2021 |
Vitamins and non-alcoholic fatty liver disease: a molecular insight S Raza, A Tewari, S Rajak, RA Sinha Liver research 5 (2), 62-71, 2021 | 54 | 2021 |
Multifaceted role of chemokines in solid tumors: From biology to therapy S Raza, S Rajak, A Tewari, P Gupta, N Chattopadhyay, RA Sinha, ... Seminars in cancer biology 86, 1105-1121, 2022 | 42 | 2022 |
Environmental toxicants and NAFLD: a neglected yet significant relationship S Rajak, S Raza, A Tewari, RA Sinha Digestive Diseases and Sciences 67 (8), 3497-3507, 2022 | 34 | 2022 |
Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse S Rajak, P Gupta, B Anjum, S Raza, A Tewari, S Ghosh, M Tripathi, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1868 (4), 166319, 2022 | 17 | 2022 |
MTORC1 inhibition drives crinophagic degradation of glucagon S Rajak, S Xie, A Tewari, S Raza, Y Wu, BH Bay, PM Yen, RA Sinha Molecular Metabolism 53, 101286, 2021 | 13 | 2021 |
Lipoic acid blocks autophagic flux and impairs cellular bioenergetics in breast cancer and reduces stemness B Chakravarti, S Rajput, S Raza, S Rajak, A Tewari, P Gupta, A Upadhyay, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1868 (10), 166455, 2022 | 10 | 2022 |
Autophagic protein ULK1 regulates FOXM1 signalling in human hepatoma cells S Rajak, S Raza, A Tewari, S Yadav, S Ghosh, PM Yen, RA Sinha Biochemical and Biophysical Research Communications 532 (4), 570-575, 2020 | 6 | 2020 |
ULK1 inhibition attenuates telomerase activity in hepatic cells S Raza, S Rajak, J Srivastava, A Tewari, P Gupta, B Chakravarti, S Ghosh, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1869 (12), 119355, 2022 | 4 | 2022 |
Fructose-induced perturbation in cellular proteostasis via RPS6KB1 promotes hepatic steatosis S Raza, A Shahi, P Medhe, A Tewari, P Gupta, S Rajak, B Chakravarti, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1871 (1), 119597, 2024 | 3 | 2024 |
Pharmacological inhibition of CFTR attenuates nonalcoholic steatohepatitis (NASH) progression in mice S Rajak, A Tewari, S Raza, P Gupta, B Chakravarti, B Anjum, M Tripathi, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1869 (4), 166662, 2023 | 3 | 2023 |
Targeting extracellular RNA mitigates hepatic lipotoxicity and liver injury in NASH A Tewari, S Rajak, S Raza, P Gupta, B Chakravarti, J Srivastava, ... Cells 12 (14), 1845, 2023 | 2 | 2023 |
Liver specific thyroid hormone receptor-β agonism alleviates alcoholic steatohepatitis (ASH) in mice A Shahi, A Yadav, S Rajak, S Raza, A Tewari, P Gupta, RA Sinha Biochemical and Biophysical Research Communications, 150742, 2024 | | 2024 |